Mitzi Chang

Mitzi Chang

Mitzi Chang

Mitzi Chang, a partner in Goodwin’s Technology Companies & Life Sciences Group, focuses her practice on corporate and securities law, representing public and private companies, venture capital and private equity firms and investment banks in capital markets transactions, mergers and acquisitions, venture capital financings, SEC reporting and other general corporate and securities matters. Ms. Chang advises companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition. Ms. Chang also has substantial intellectual property transactional experience within the digital media, online services, advertising and entertainment space.

In addition, Ms. Chang is a member of the firm's Impact and Responsible Investing Practice. She currently serves on the firm’s Committee on Racial and Ethnic Diversity and is on the hiring committee for Goodwin’s San Francisco office.

Professional Activities

Ms. Chang is a member of the American Bar Association and the State Bar of California.

Professional Experience

Prior to joining Goodwin, Ms. Chang was a senior counsel at CBS Interactive Inc. (formerly CNET Networks, Inc.) from 2005-2008, where she advised and supported the company's Games, Music & Lifestyle and TV Entertainment divisions in their business-related matters as well as the company in its acquisitions, securities-related and other corporate matters. From 2002-2005, she was an associate in the corporate department of the San Francisco office of Latham & Watkins LLP.


While attending law school, Ms. Chang was a Notes and Comments Editor for The Tax Lawyer, for which she authored “Reasonableness, First Impression, and the Accuracy-Related Penalty: Neonatology Associates v. Commissioner” (2001).

Areas of Practice


Ms. Chang has recently represented:

  • aTyr Pharma, Inc. in its $76 million Series E preferred stock financing and $75 million initial public offering
  • Fate Therapeutics, Inc. in its $40 million initial public offering, $30 million follow-on public offering and $8 million private placement with Juno Therapeutics
  • Teva Pharmaceuticals Industries, Ltd. in its $3.2 billion acquisition of Auspex Pharmaceuticals, Inc.
  • ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
  • Greycroft Partners in its investment in Yeahka, a Chinese mobile payment service provider
  • ThredUp, Inc. in its $81 million Series E preferred stock financing
  • Spotlite, Inc. in its sale to Rally Health
  • Onyx Pharmaceuticals, Inc. in its $10.4 billion sale to Amgen
  • Courier Corporation in its acquisition of FastPencil, Inc.
  • InsightsOne Systems, Inc. in its sale to Apigee Corporation
  • Industry Ventures in is investment in TheRealReal
  • Imperva in its $90 million initial public offering
  • Companies in acquihire transactions with Facebook, Yahoo!, and Ebay
  • Whiskey Media in its sale transactions with CBS Interactive and BermanBraun



J.D., 2002
Georgetown University Law Center
B.A., 1999
University of California, Berkeley

(magna cum laude, Phi Beta Kappa)



Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers